PMID: 6103437May 24, 1980Paper

Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content

Lancet
L E BöttigerB Westerholm

Abstract

The introduction of low-oestrogen oral contraceptives in Sweden and the concomitant disappearance of high-dose preparations did not result in a lowering of the mortality of fertile women from thromboembolic disease. Morbidity due to thromboembolism seems to have fallen, and the number of thromboembolic incidents reported to the Swedish Adverse Drug Reaction Committee decreased dramatically. The decrease was due exclusively to a reduction in venous thromboembolic disease: the frequency of arterial complications (cerebral and coronary) remained constant.

References

Aug 11, 1973·British Medical Journal·L E Böttiger, B Westerholm

❮ Previous
Next ❯

Citations

Jan 1, 1985·Neuroradiology·S Godon-HardyD Fredy
Jun 1, 1991·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·M op ten Berg
Sep 1, 1993·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·C MassafraG Colombini
Sep 1, 1994·Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception·N BruyniksI Rákóczi
Mar 1, 1992·Journal of General Internal Medicine·M C Lindberg
Nov 15, 2002·International Journal of Hematology·Kwang Kon Koh
Aug 1, 1989·European Journal of Obstetrics, Gynecology, and Reproductive Biology·R J Derham, P C Buchan
Nov 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A SteinmetzH Kaffarnik
May 15, 1995·Thrombosis Research·A A SalehE F Mammen
Oct 1, 1994·Pharmacology & Therapeutics·J A Gevers Leuven
Jan 1, 1987·Journal of Adolescent Health Care : Official Publication of the Society for Adolescent Medicine·I N Cholst, A T Carlon
Apr 11, 2003·Clinics in Chest Medicine·John A Heit
Jul 1, 1990·Journal of Biosocial Science·U Högberg, S Wall
Jun 6, 2002·Acta Obstetricia Et Gynecologica Scandinavica·Viveca OdlindArne Victor
Oct 1, 1995·British Journal of Haematology·O OlivieriC Russo
Dec 1, 1990·Clinical Otolaryngology and Allied Sciences·R G Williams, M P Yardley
Jul 1, 1995·Journal of Internal Medicine·T KosterF M Helmerhorst
Jul 1, 1993·Journal of Gastroenterology and Hepatology·G Chu, G C Farrell
May 1, 1991·British Journal of Obstetrics and Gynaecology
Jan 1, 1993·British Journal of Obstetrics and Gynaecology·S J CampbellS J Machin
Oct 1, 1992·The Journal of Dermatologic Surgery and Oncology·F VinM Levardon
Mar 1, 1997·Acta Obstetricia Et Gynecologica Scandinavica·O Lidegaard
May 14, 1998·Archives of Disease in Childhood·E WeimannH J Böhles
May 21, 1983·British Medical Journal·K Detering, R A Wiseman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.